Vytlačiť
1.
- Efficacy and safety of regorafenib or fruquintinib plus camrelizumab in patients with microsatellite stable and/or proficient mismatch repair metastatic colorectal cancer: an observational pilot study / Feng-E Jiang ... [et al.]. Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Vol. 68, no. 4 (2021), s. 861-866 : ilustr., obr., tab.
- C 720